Loading...
Header Logo
Keywords
Last Name
Institution

GEORGE J CHANG

TitleProfessor
InstitutionMD Anderson
DepartmentSurgical Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Malakorn S, Yang Y, Bednarski BK, Kaur H, You YN, Holliday EB, Dasari A, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation? Dis Colon Rectum. 2019 Oct; 62(10):1158-1166. PMID: 31490825.
      View in: PubMed
    2. Lowenstein LM, Volk RJ, Cuddy A, Hempstead AP, You YN, Van Loon K, Millas S, Meyerhardt JA, Gavin P, Chang GJ. Patients' information needs and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study. BMJ Open. 2019 Aug 15; 9(8):e025888. PMID: 31420381.
      View in: PubMed
    3. Winiwarter S, Chang G, Desai P, Menzel K, Faller B, Arimoto R, Keefer C, Broccatell F. Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry Datasets. Mol Pharm. 2019 Sep 03; 16(9):4077-4085. PMID: 31348668.
      View in: PubMed
    4. Eng C, Jácome AA, Das P, Chang GJ, Rodriguez-Bigas M, Skibber JM, Wolff RA, Qiao W, Xing Y, Sethi S, Ohinata A, Crane CH. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal. Clin Colorectal Cancer. 2019 Jul 02. PMID: 31350201.
      View in: PubMed
    5. Yang Y, Malakorn S, Zafar SN, Nickerson TP, Sandhu L, Chang GJ. Superior Mesenteric Vein-First Approach to Robotic Complete Mesocolic Excision for Right Colectomy: Technique and Preliminary Outcomes. Dis Colon Rectum. 2019 07; 62(7):894-897. PMID: 31188192.
      View in: PubMed
    6. Malakorn S, Chang GJ. The Authors Reply. Dis Colon Rectum. 2019 06; 62(6):e30-e31. PMID: 31094965.
      View in: PubMed
    7. Yang Y, Malakorn S, Maldonado K, Bednarski BK, Kiernan CM, Thirumurthi S, Chang GJ, You YN. The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon. Ann Surg Oncol. 2019 Aug; 26(8):2514-2515. PMID: 31102088.
      View in: PubMed
    8. Halverson AL, Morris AM, Cleary RK, Chang GJ. For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection? Ann Surg Oncol. 2019 Aug; 26(8):2497-2506. PMID: 31025228.
      View in: PubMed
    9. You YN, Borras E, Chang K, Price BA, Mork M, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Meric-Bernstam F, Vilar E. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum. 2019 04; 62(4):429-437. PMID: 30730459.
      View in: PubMed
    10. Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, Peters WR, Maun DC, Chang GJ, Herline A, Fichera A, Mutch MG, Wexner SD, Whiteford MH, Marks J, Birnbaum E, Margolin DA, Larson DW, Marcello PW, Posner MC, Read TE, Monson JRT, Wren SM, Pisters PWT, Nelson H. Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial. Ann Surg. 2019 Apr; 269(4):589-595. PMID: 30080730.
      View in: PubMed
    11. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20?mm colon polyps. Endosc Int Open. 2019 Mar; 7(3):E361-E366. PMID: 30834295.
      View in: PubMed
    12. Massarweh NN, Chang GJ. Translating Research Findings Into Practice-The Unfulfilled and Unclear Mission of Observational Data. JAMA Surg. 2019 Feb 01; 154(2):103-104. PMID: 30422255.
      View in: PubMed
    13. Koutsoukas A, Chang G, Keefer CE. In-Silico Extraction of Design Ideas Using MMPA-by-QSAR and its Application on ADME Endpoints. J Chem Inf Model. 2019 Jan 28; 59(1):477-485. PMID: 30497262.
      View in: PubMed
    14. Subramanian M, Liu J, Greenberg C, Schumacher J, Chang GJ, McMurry TL, Francescatti AB, Semenkovich TR, Hudson JL, Meyers BF, Puri V, Kozower BD. Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better? J Thorac Cardiovasc Surg. 2019 Mar; 157(3):1205-1217.e2. PMID: 31130741.
      View in: PubMed
    15. McMurry TL, Stukenborg GJ, Kessler LG, Colditz GA, Wong ML, Francescatti AB, Jones DR, Schumacher JR, Greenberg CC, Chang GJ, Winchester DP, McKellar DP, Kozower BD. More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study. Ann Surg. 2018 10; 268(4):632-639. PMID: 30004919.
      View in: PubMed
    16. Berian JR, Cuddy A, Francescatti AB, O'Dwyer L, Nancy You Y, Volk RJ, Chang GJ. Correction to: A systematic review of patient perspectives on surveillance after colorectal cancer treatment. J Cancer Surviv. 2018 10; 12(5):721. PMID: 29951829.
      View in: PubMed
    17. Wong ML, McMurry TL, Schumacher JR, Hu CY, Stukenborg GJ, Francescatti AB, Greenberg CC, Chang GJ, McKellar DP, Walter LC, Kozower BD. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03). J Oncol Pract. 2018 10; 14(10):e631-e643. PMID: 30207852.
      View in: PubMed
    18. Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM, Wind JK, Shaw MC, Heon N, Shi Q, Ginos B, Nelson GD, Meyers JP, Chang GJ, Mamon HJ, Weiser MR, Kolevska T, Reeve BB, Bruner DW, Schrag D. Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048. J Clin Oncol. 2018 Sep 11; JCO2018788620. PMID: 30204536.
      View in: PubMed
    19. Cleary RK, Morris AM, Chang GJ, Halverson AL. Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach? Ann Surg Oncol. 2018 Nov; 25(12):3587-3595. PMID: 30187281.
      View in: PubMed
    20. Malakorn S, Ouchi A, Sammour T, Bednarski BK, Chang GJ. Robotic Lateral Pelvic Lymph Node Dissection after Neoadjuvant Chemoradiation: View from the West. Dis Colon Rectum. 2018 09; 61(9):1119-1120. PMID: 30086062.
      View in: PubMed
    21. Sammour T, Chang GJ. Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial? Ann Gastroenterol Surg. 2018 Sep; 2(5):348-350. PMID: 30238075.
      View in: PubMed
    22. Pacyna JE, Kim S, Yost K, Sedlacek H, Petereit D, Kaur J, Rapkin B, Grubb R, Paskett E, Chang GJ, Sloan J, Basch E, Major B, Novotny P, Taylor J, Buckner J, Parsons JK, Morris M, Tilburt JC. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD. BMC Cancer. 2018 Aug 06; 18(1):788. PMID: 30081846.
      View in: PubMed
    23. Mason MC, Tran Cao HS, Awad SS, Farjah F, Chang GJ, Massarweh NN. Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. Ann Surg. 2018 08; 268(2):303-310. PMID: 28498235.
      View in: PubMed
    24. Loehrer AP, Chang GJ. Implications of the Affordable Care Act on Surgery and Cancer Care. Surg Oncol Clin N Am. 2018 10; 27(4):603-614. PMID: 30213405.
      View in: PubMed
    25. Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Adv Radiat Oncol. 2018 Oct-Dec; 3(4):595-600. PMID: 30370360.
      View in: PubMed
    26. Kolarich A, George TJ, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer. 2018 09 01; 124(17):3510-3519. PMID: 29984547.
      View in: PubMed
    27. Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Nancy You YQ, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol. 2018 07; 41(7):632-637. PMID: 27755060.
      View in: PubMed
    28. Chang GJ. Is There Validity in Propensity Score-Matched Estimates of Adjuvant Chemotherapy Effects for Patients With Rectal Cancer? JAMA Oncol. 2018 07 01; 4(7):921-923. PMID: 29710090.
      View in: PubMed
    29. Sammour T, Chang GJ. Robotic surgery for rectal cancer: the future? Minerva Chir. 2018 Dec; 73(6):574-578. PMID: 29806755.
      View in: PubMed
    30. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA. 2018 05 22; 319(20):2104-2115. PMID: 29800181.
      View in: PubMed
    31. Schumacher JR, Neuman HB, Chang GJ, Kozower BD, Edge SB, Yu M, Vanness DJ, Si Y, Jacobs EA, Francescatti AB, Spears PA, Havlena J, Adesoye T, McKellar D, Winchester D, Burnside ES, Greenberg CC. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Ann Surg Oncol. 2018 Sep; 25(9):2587-2595. PMID: 29777402.
      View in: PubMed
    32. Delitto D, George TJ, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst. 2018 05 01; 110(5):460-466. PMID: 29165692.
      View in: PubMed
    33. Sandhu L, Chang GJ. Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer. Ann Surg Oncol. 2018 12; 25(13):4049-4050. PMID: 29700670.
      View in: PubMed
    34. Chang GJ. Leveraging Data, the Next Big Advance for Quality Improvement in Colorectal Cancer. Dis Colon Rectum. 2018 04; 61(4):415-416. PMID: 29521818.
      View in: PubMed
    35. Sammour T, Malakorn S, Bednarski BK, Kaur H, Shin US, Messick C, You YN, Chang GJ. Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database. Ann Surg. 2018 03; 267(3):521-526. PMID: 27997470.
      View in: PubMed
    36. Sada YH, Tran Cao HS, Chang GJ, Artinyan A, Musher BL, Smaglo BG, Massarweh NN. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. J Surg Res. 2018 06; 226:15-23. PMID: 29661280.
      View in: PubMed
    37. Riccardi K, Ryu S, Lin J, Yates P, Tess D, Li R, Singh D, Holder BR, Kapinos B, Chang G, Di L. Comparison of Species and Cell-Type Differences in Fraction Unbound of Liver Tissues, Hepatocytes, and Cell Lines. Drug Metab Dispos. 2018 04; 46(4):415-421. PMID: 29437874.
      View in: PubMed
    38. Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF, Chang GJ. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum. 2018 Jan; 61(1):77-83. PMID: 29215474.
      View in: PubMed
    39. Voong KR, Rashid A, Crane CH, Minsky BD, Krishnan S, Yao JC, Wolff RA, Skibber JM, Feig BW, Chang GJ, Das P. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. Am J Clin Oncol. 2017 Dec; 40(6):555-560. PMID: 26237193.
      View in: PubMed
    40. Mason MC, Chang GJ, Petersen LA, Sada YH, Tran Cao HS, Chai C, Berger DH, Massarweh NN. National Quality Forum Colon Cancer Quality Metric Performance: How Are Hospitals Measuring Up? Ann Surg. 2017 12; 266(6):1013-1020. PMID: 27617852.
      View in: PubMed
    41. Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol. 2017 Dec; 8(6):990-997. PMID: 29299359.
      View in: PubMed
    42. Loehrer AP, Chang DC, Song Z, Chang GJ. Health Reform and Utilization of High-Volume Hospitals for Complex Cancer Operations. J Oncol Pract. 2018 01; 14(1):e42-e50. PMID: 29155612.
      View in: PubMed
    43. Carlos RC, Sicks JD, Chang GJ, Lyss AP, Stewart TL, Sung L, Weaver KE. Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners. J Am Coll Radiol. 2017 Dec; 14(12):1530-1537. PMID: 29055605.
      View in: PubMed
    44. Keefer CE, Chang G. The use of matched molecular series networks for cross target structure activity relationship translation and potency prediction. Medchemcomm. 2017 Nov 01; 8(11):2067-2078. PMID: 30108724.
      View in: PubMed
    45. Chang GJ, Gonen M. Prognostic and Predictive Ability of Tumor Sidedness: Another Vexing Difference Between Localized and Advanced Colon Cancer. JAMA Oncol. 2017 10 01; 3(10):1314-1315. PMID: 28594984.
      View in: PubMed
    46. Chang GJ. Selective Lateral Pelvic Lymph Dissection for Rectal Cancer. Ann Surg Oncol. 2017 Dec; 24(13):3797-3798. PMID: 28956307.
      View in: PubMed
    47. Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. Ann Surg Oncol. 2017 Dec; 24(13):4051-4058. PMID: 28936799.
      View in: PubMed
    48. Chang GJ. Can Prognostic Scoring Tools Predict Treatment Outcomes? Dis Colon Rectum. 2017 Sep; 60(9):875-876. PMID: 28796723.
      View in: PubMed
    49. Ikoma N, Raghav K, Chang G. An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma. Surg Oncol Clin N Am. 2017 10; 26(4):667-687. PMID: 28923224.
      View in: PubMed
    50. Sammour T, Chang GJ. Lateral Node Dissection in Low Rectal Cancer: Time for a Global Approach? Ann Surg. 2017 08; 266(2):208-209. PMID: 28437315.
      View in: PubMed
    51. Price BA, Bednarski BK, You YN, Manandhar M, Dean EM, Alawadi ZM, Bryce Speer B, Gottumukkala V, Weldon M, Massey RL, Wang X, Qiao W, Chang GJ. Accelerated enhanced Recovery following Minimally Invasive colorectal cancer surgery (RecoverMI): a study protocol for a novel randomised controlled trial. BMJ Open. 2017 Jul 20; 7(7):e015960. PMID: 28729319.
      View in: PubMed
    52. Chang GJ. Treatment of Locally Advanced Rectal Cancer: Turning Good Rationale Into Good Evidence? Dis Colon Rectum. 2017 Jul; 60(7):649-650. PMID: 28594712.
      View in: PubMed
    53. Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol. 2017 Aug 10; 35(23):2631-2638. PMID: 28657814.
      View in: PubMed
    54. Berian JR, Cuddy A, Francescatti AB, O'Dwyer L, Nancy You Y, Volk RJ, Chang GJ. A systematic review of patient perspectives on surveillance after colorectal cancer treatment. J Cancer Surviv. 2017 Oct; 11(5):542-552. PMID: 28639159.
      View in: PubMed
    55. Malakorn S, Chang GJ. Treatment of rectal cancer in the East and West: Should it be different? Surgery. 2017 08; 162(2):315-316. PMID: 28619666.
      View in: PubMed
    56. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol. 2017 Jun; 40(3):277-282. PMID: 27028350.
      View in: PubMed
    57. You YN, Shiozaki H, Lee JE, Passot G, Goumard C, Okuno M, Aloia TA, Eng C, Chang G, Vauthey JN, Conrad C. Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection. Ann Surg Oncol. 2017 Sep; 24(9):2595. PMID: 28510798.
      View in: PubMed
    58. Malakorn S, Sammour T, Pisters LL, Chang GJ. Robotic Total Pelvic Exenteration. Dis Colon Rectum. 2017 May; 60(5):555. PMID: 28383456.
      View in: PubMed
    59. Sandhu L, Chang GJ. Which Surgical Approach Is Best for Management of Rectal Cancer?: Does the End Point Tell How It Ends? JAMA Surg. 2017 04 19; 152(4):e165659. PMID: 28196188.
      View in: PubMed
    60. Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):455-464. PMID: 29114614.
      View in: PubMed
    61. Sturgeon JD, Crane CH, Krishnan S, Minsky BD, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Eng C, Das P. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Am J Clin Oncol. 2017 Apr; 40(2):163-166. PMID: 25222072.
      View in: PubMed
    62. Sammour T, Price BA, Krause KJ, Chang GJ. Nonoperative Management or 'Watch and Wait' for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal. Ann Surg Oncol. 2017 Jul; 24(7):1904-1915. PMID: 28324284.
      View in: PubMed
    63. Ali SM, Pawlik TM, Rodriguez-Bigas MA, Monson JRT, Chang GJ, Larson DW. Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis. Ann Surg Oncol. 2018 Jan; 25(1):32-37. PMID: 28224365.
      View in: PubMed
    64. Malakorn S, Sammour T, Bednarski B, You YN, Chang GJ. Three Different Approaches to the Inferior Mesenteric Artery during Robotic D3 Lymphadenectomy for Rectal Cancer. Ann Surg Oncol. 2017 Jul; 24(7):1923. PMID: 28213788.
      View in: PubMed
    65. Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol. 2017 01; 122(1):146-151. PMID: 28057329.
      View in: PubMed
    66. Paquette IM, Madoff RD, Sigurdson ER, Chang GJ. Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer. Ann Surg Oncol. 2018 Jan; 25(1):38-45. PMID: 27942902.
      View in: PubMed
    67. Liu C, Eng C, Shen J, Lu Y, Takata Y, Mehdizadeh A, Chang GJ, Rodriguez-Bigas MA, Li Y, Chang P, Mao Y, Hassan MM, Wang F, Li D. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget. 2016 Nov 15; 7(46):76250-76260. PMID: 27788488.
      View in: PubMed
    68. Wong ML, McMurry TL, Stukenborg GJ, Francescatti AB, Amato-Martz C, Schumacher JR, Chang GJ, Greenberg CC, Winchester DP, McKellar DP, Walter LC, Kozower BD. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study. Lung Cancer. 2016 12; 102:108-117. PMID: 27987578.
      View in: PubMed
    69. Chang G, Huard K, Kauffman GW, Stepan AF, Keefer CE. A multi-endpoint matched molecular pair (MMP) analysis of 6-membered heterocycles. Bioorg Med Chem. 2017 01 01; 25(1):381-388. PMID: 27840138.
      View in: PubMed
    70. Kaplan JA, Brinson Z, Hofer R, O'Sullivan P, Chang A, Horvath H, Chang GJ, Finlayson E. Early learners as health coaches for older adults preparing for surgery. J Surg Res. 2017 03; 209:184-190. PMID: 28032558.
      View in: PubMed
    71. Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer. 2017 04 01; 123(7):1124-1133. PMID: 27479827.
      View in: PubMed
    72. de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016 09 01; 34(25):3039-46. PMID: 27432916.
      View in: PubMed
    73. Glasgow SC, Morris AM, Baxter NN, Fleshman JW, Alavi KS, Luchtefeld MA, Monson JR, Chang GJ, Temple LK. Development of The American Society of Colon and Rectal Surgeons' Rectal Cancer Surgery Checklist. Dis Colon Rectum. 2016 Jul; 59(7):601-6. PMID: 27270511.
      View in: PubMed
    74. Massarweh NN, Artinyan A, Chang GJ. Neoadjuvant treatment for rectal cancer-A value-based proposition. J Surg Oncol. 2016 Sep; 114(3):304-10. PMID: 27111410.
      View in: PubMed
    75. Shin US, Nancy You Y, Nguyen AT, Bednarski BK, Messick C, Maru DM, Dean EM, Nguyen ST, Hu CY, Chang GJ. Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer. Ann Surg Oncol. 2016 07; 23(7):2249-57. PMID: 26856720.
      View in: PubMed
    76. Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D, Matsubara N, Bülow S, Jespersen N, Clark SK, Erdman SH, Markowitz AJ, Bernstein I, De Haas N, Syngal S, Moeslein G. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016 Jul; 84(1):115-125.e4. PMID: 26769407.
      View in: PubMed
    77. Yamasaki A, Mise Y, Mise Y, Lee JE, Aloia TA, Katz MH, Chang GJ, Lillemoe KD, Raut CP, Conrad C. Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants. Surgery. 2016 May; 159(5):1260-8. PMID: 26706609.
      View in: PubMed
    78. Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH, Greene FL, Fleshman JW, Abbas MA, Peters W, Noyes K, Monson JR, Fleming FJ. High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action. Ann Surg. 2015 Dec; 262(6):891-8. PMID: 26473651.
      View in: PubMed
    79. Patel S, Chang GJ. Primary Tumor Resection in Metastatic Colorectal Cancer: Please Pass the Salt. JAMA Oncol. 2015 Dec; 1(9):1213-4. PMID: 26378904.
      View in: PubMed
    80. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H. Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA. 2015 Oct 06; 314(13):1346-55. PMID: 26441179.
      View in: PubMed
    81. Morris VK, Rashid A, Rodriguez-Bigas M, Das P, Chang G, Ohinata A, Rogers J, Crane C, Wolff RA, Eng C. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. Oncologist. 2015 Nov; 20(11):1247-52. PMID: 26382740.
      View in: PubMed
    82. Hu CY, Bailey CE, Chang GJ. Less Surgery, Improved Survival From Stage IV Colorectal Cancer?-Reply. JAMA Surg. 2015 Aug; 150(8):819-20. PMID: 26107989.
      View in: PubMed
    83. Steele SR, Chang GJ, Hendren S, Weiser M, Irani J, Buie WD, Rafferty JF. Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer. Dis Colon Rectum. 2015 Aug; 58(8):713-25. PMID: 26163950.
      View in: PubMed
    84. Massarweh NN, Haynes AB, Chiang YJ, Chang GJ, You YN, Feig BW, Cormier JN. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough? Ann Surg. 2015 Aug; 262(2):312-20. PMID: 25185467.
      View in: PubMed
    85. Dineen S, Lynch PM, Rodriguez-Bigas MA, Bannon S, Taggart M, Reeves C, Modaro C, Overman M, Chang GJ, Skibber JM, You YN. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. J Natl Compr Canc Netw. 2015 Jul; 13(7):865-72. PMID: 26150580.
      View in: PubMed
    86. Chang GJ, Kopetz S. Coordination of care in colon cancer. Cancer. 2015 Sep 15; 121(18):3201-2. PMID: 26043269.
      View in: PubMed
    87. Kneuertz PJ, Chang GJ, Hu CY, Rodriguez-Bigas MA, Eng C, Vilar E, Skibber JM, Feig BW, Cormier JN, You YN. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 2015 May; 150(5):402-9. PMID: 25806815.
      View in: PubMed
    88. Bailey CE, Hu CY, You YN, Kaur H, Ernst RD, Chang GJ. Variation in positron emission tomography use after colon cancer resection. J Oncol Pract. 2015 May; 11(3):e363-72. PMID: 25852143.
      View in: PubMed
    89. Massarweh NN, Hu CY, Rodriguez-Bigas MA, Chang GJ. Reply to N.H. Turner et al and L. Dziki et al. J Clin Oncol. 2015 Apr 20; 33(12):1412-3. PMID: 25800769.
      View in: PubMed
    90. Hu CY, Bailey CE, You YN, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg. 2015 Mar 01; 150(3):245-51. PMID: 25588105.
      View in: PubMed
    91. Zheng Z, Jemal A, Lin CC, Hu CY, Chang GJ. Comparative effectiveness of laparoscopy vs open colectomy among nonmetastatic colon cancer patients: an analysis using the National Cancer Data Base. J Natl Cancer Inst. 2015 Mar; 107(3). PMID: 25663688.
      View in: PubMed
    92. Chang GJ. Simulating watch and wait for rectal cancer. Dis Colon Rectum. 2015 Feb; 58(2):155-6. PMID: 25585071.
      View in: PubMed
    93. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015 Jan; 150(1):17-22. PMID: 25372703.
      View in: PubMed
    94. Eng C, Chang GJ, You YN, Das P, Rodriguez-Bigas M, Xing Y, Vauthey JN, Rogers JE, Ohinata A, Pathak P, Sethi S, Phillips JK, Crane CH, Wolff RA. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget. 2014 Nov 30; 5(22):11133-42. PMID: 25373735.
      View in: PubMed
    95. Monson JR, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, Chang GJ, Dietz DW. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg. 2014 Oct; 260(4):625-31; discussion 631-2. PMID: 25203879.
      View in: PubMed
    96. Massarweh NN, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Cormier JN, Feig BW, Chang GJ. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74. PMID: 25092785.
      View in: PubMed
    97. Bailey CE, Tran Cao HS, Hu CY, Chang GJ, Feig BW, Rodriguez-Bigas MA, Nguyen ST, Skibber JM, You YN. Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J Gastrointest Surg. 2015 Jan; 19(1):180-8; discussio 188. PMID: 25213581.
      View in: PubMed
    98. Chang GJ, Greenberg CC, Kozower BD, Boughey JC, Francescatti A, Mckellar DP, Winchester DP. NCDB and ACS-CRP: Working together to develop risk-stratified strategies for surveillance. Bull Am Coll Surg. 2014 Aug; 99(8):57-8. PMID: 25145051.
      View in: PubMed
    99. Chang GJ. 'Watch-and-wait' for rectal cancer: what's the way forward? Oncology (Williston Park). 2014 Jul; 28(7):617-8. PMID: 25144283.
      View in: PubMed
    100. Phatak UR, Li LT, Karanjawala B, Chang GJ, Kao LS. Systematic review of educational interventions for ostomates. Dis Colon Rectum. 2014 Apr; 57(4):529-37. PMID: 24608311.
      View in: PubMed
    101. Massarweh NN, Chiang YJ, Xing Y, Chang GJ, Haynes AB, You YN, Feig BW, Cormier JN. Association between travel distance and metastatic disease at diagnosis among patients with colon cancer. J Clin Oncol. 2014 Mar 20; 32(9):942-8. PMID: 24516014.
      View in: PubMed
    102. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8. PMID: 24510523.
      View in: PubMed
    103. Maru DM, Agarwal AA, Hu CY, Chang GJ. Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery? Cancer. 2014 Apr 15; 120(8):1282. PMID: 24474599.
      View in: PubMed
    104. Haynes AB, You YN, Hu CY, Eng C, Kopetz ES, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer. 2014 Apr 15; 120(8):1162-70. PMID: 24474245.
      View in: PubMed
    105. Greenberg C, Chang GJ, Nelson H. Patient-centered outcomes research: is this really something new? Bull Am Coll Surg. 2014 Jan; 99(1):51-2. PMID: 24552033.
      View in: PubMed
    106. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):301-5. PMID: 24315563.
      View in: PubMed
    107. Phatak UR, Kao LS, You YN, Rodriguez-Bigas MA, Skibber JM, Feig BW, Nguyen S, Cantor SB, Chang GJ. Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol. 2014 Feb; 21(2):507-12. PMID: 24085329.
      View in: PubMed
    108. Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer. 2013 Dec 15; 119(24):4231-41. PMID: 24089344.
      View in: PubMed
    109. Lee S, Reha JL, Tzeng CW, Massarweh NN, Chang GJ, Hetz SP, Fleming JB, Lee JE, Katz MH. Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system. Ann Surg Oncol. 2013 Dec; 20(13):4073-9. PMID: 24002535.
      View in: PubMed
    110. Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer. 2013 Nov 01; 119(21):3769-75. PMID: 24037775.
      View in: PubMed
    111. Russell MC, You YN, Hu CY, Cormier JN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Nelson H, Chang GJ. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013 Aug; 148(8):769-77. PMID: 23803722.
      View in: PubMed
    112. Krishnan S, Chang GJ. KRAS mutations and rectal cancer response to chemoradiation: are we closer to personalization of therapy? Ann Surg Oncol. 2013 Oct; 20(11):3359-62. PMID: 23864308.
      View in: PubMed
    113. Chang GJ. Emphasizing surgery for colon cancer. Dis Colon Rectum. 2013 Jul; 56(7):805-7. PMID: 23739185.
      View in: PubMed
    114. Badgwell B, Stanley J, Chang GJ, Katz MH, Lin HY, Ning J, Klimberg SV, Cormier JN. Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery. J Surg Oncol. 2013 Sep; 108(3):182-6. PMID: 23804149.
      View in: PubMed
    115. Overman MJ, Fournier K, Hu CY, Eng C, Taggart M, Royal R, Mansfield P, Chang GJ. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Ann Surg. 2013 Jun; 257(6):1072-8. PMID: 23001080.
      View in: PubMed
    116. Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum. 2013 May; 56(5):551-9. PMID: 23575393.
      View in: PubMed
    117. Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF, Buie WD, Rafferty J. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2013 May; 56(5):535-50. PMID: 23575392.
      View in: PubMed
    118. Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. Br J Cancer. 2013 Apr 16; 108(7):1508-14. PMID: 23470470.
      View in: PubMed
    119. Greenberg CC, Wind JK, Chang GJ, Chen RC, Schrag D. Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium. J Comp Eff Res. 2013 Mar; 2(2):117-25. PMID: 24236554.
      View in: PubMed
    120. Hu CY, Xing Y, Cormier JN, Chang GJ. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer. 2013 May 15; 119(10):1900-7. PMID: 23408226.
      View in: PubMed
    121. Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8. PMID: 23397153.
      View in: PubMed
    122. Skinner HD, Crane CH, Garrett CR, Eng C, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Kelly P, Sandulache VC, Delclos ME, Krishnan S, Das P. Metformin use and improved response to therapy in rectal cancer. Cancer Med. 2013 Feb; 2(1):99-107. PMID: 24133632.
      View in: PubMed
    123. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Feig B, Nguyen S, Hu CY, Chang GJ. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2013 Feb; 56(2):135-41. PMID: 23303140.
      View in: PubMed
    124. Mirnezami R, Chang GJ, Das P, Chandrakumaran K, Tekkis P, Darzi A, Mirnezami AH. Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications. Surg Oncol. 2013 Mar; 22(1):22-35. PMID: 23270946.
      View in: PubMed
    125. Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, Hu CY, Feig BW, You YN, Cormier JN. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013 Apr 15; 119(8):1593-601. PMID: 23280510.
      View in: PubMed
    126. You YN, Roses RE, Chang GJ, Rodriguez-Bigas MA, Feig BW, Slack R, Nguyen S, Skibber JM. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum. 2012 Dec; 55(12):1213-9. PMID: 23135578.
      View in: PubMed
    127. Chagpar R, Chiang YJ, Xing Y, Cormier JN, Feig BW, Rashid A, Chang GJ, You YN. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems. Ann Surg Oncol. 2013 Apr; 20(4):1170-8. PMID: 23212760.
      View in: PubMed
    128. Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90. PMID: 22932858.
      View in: PubMed
    129. Chang GJ. Challenge of primary tumor management in patients with stage IV colorectal cancer. J Clin Oncol. 2012 Sep 10; 30(26):3165-6. PMID: 22869881.
      View in: PubMed
    130. Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD. Practice parameters for the management of colon cancer. Dis Colon Rectum. 2012 Aug; 55(8):831-43. PMID: 22810468.
      View in: PubMed
    131. Phatak UR, Pedroza C, Millas SG, Chang GJ, Lally KP, Kao LS. Revisiting the effectiveness of interventions to decrease surgical site infections in colorectal surgery: A Bayesian perspective. Surgery. 2012 Aug; 152(2):202-11. PMID: 22828141.
      View in: PubMed
    132. Di L, Keefer C, Scott DO, Strelevitz TJ, Chang G, Bi YA, Lai Y, Duckworth J, Fenner K, Troutman MD, Obach RS. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. Eur J Med Chem. 2012 Nov; 57:441-8. PMID: 22840492.
      View in: PubMed
    133. Hsu C, Rashid A, Xing Y, Chiang YJ, Chagpar RB, Fournier KF, Chang GJ, You YN, Feig BW, Cormier JN. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol. 2013 Feb; 107(2):136-43. PMID: 22767417.
      View in: PubMed
    134. Katz MH, Hu CY, Fleming JB, Pisters PW, Lee JE, Chang GJ. Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. Arch Surg. 2012 Jun; 147(6):513-9. PMID: 22351874.
      View in: PubMed
    135. Bujko K, Rutkowski A, Chang GJ, Michalski W, Chmielik E, Kusnierz J. Is the 1-cm Rule of Distal Bowel Resection Margin in Rectal Cancer Based on Clinical Evidence? A Systematic Review. Indian J Surg Oncol. 2012 Jun; 3(2):139-46. PMID: 23728157.
      View in: PubMed
    136. Varma MV, Chang G, Lai Y, Feng B, El-Kattan AF, Litchfield J, Goosen TC. Physicochemical property space of hepatobiliary transport and computational models for predicting rat biliary excretion. Drug Metab Dispos. 2012 Aug; 40(8):1527-37. PMID: 22580868.
      View in: PubMed
    137. Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S, Chang GJ. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg. 2012 Aug; 215(2):262-70. PMID: 22560316.
      View in: PubMed
    138. Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012 May 20; 30(15):1770-6. PMID: 22493423.
      View in: PubMed
    139. Hyngstrom JR, Hu CY, Xing Y, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Cormier JN, Chang GJ. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21. PMID: 22476818.
      View in: PubMed
    140. Chang GJ, You YN, Park IJ, Kaur H, Hu CY, Rodriguez-Bigas MA, Skibber JM, Ernst RD. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis Colon Rectum. 2012 Apr; 55(4):371-7. PMID: 22426259.
      View in: PubMed
    141. Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, Chang GJ, Skibber JM, Ernst RD. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012 Mar-Apr; 32(2):389-409. PMID: 22411939.
      View in: PubMed
    142. Chagpar R, Xing Y, Chiang YJ, Feig BW, Chang GJ, You YN, Cormier JN. Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol. 2012 Mar 20; 30(9):972-9. PMID: 22355049.
      View in: PubMed
    143. Park IJ, You YN, Schlette E, Nguyen S, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Reverse-hybrid robotic mesorectal excision for rectal cancer. Dis Colon Rectum. 2012 Feb; 55(2):228-33. PMID: 22228169.
      View in: PubMed
    144. Overman MJ, Hu CY, Kopetz S, Abbruzzese JL, Wolff RA, Chang GJ. A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. Ann Surg Oncol. 2012 May; 19(5):1439-45. PMID: 22187121.
      View in: PubMed
    145. You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med. 2012 Feb 13; 172(3):287-9. PMID: 22157065.
      View in: PubMed
    146. Bujko K, Rutkowski A, Chang GJ, Michalski W, Chmielik E, Kusnierz J. Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol. 2012 Mar; 19(3):801-8. PMID: 21879269.
      View in: PubMed
    147. Chang GJ. Primary tumor resection in stage IV colorectal cancer: the debate continues. Dis Colon Rectum. 2011 Aug; 54(8):919-20. PMID: 21730777.
      View in: PubMed
    148. Keefer CE, Chang G, Kauffman GW. Extraction of tacit knowledge from large ADME data sets via pairwise analysis. Bioorg Med Chem. 2011 Jun 15; 19(12):3739-49. PMID: 21616672.
      View in: PubMed
    149. Di L, Umland JP, Chang G, Huang Y, Lin Z, Scott DO, Troutman MD, Liston TE. Species independence in brain tissue binding using brain homogenates. Drug Metab Dispos. 2011 Jul; 39(7):1270-7. PMID: 21474681.
      View in: PubMed
    150. Al-Refaie WB, Hu CY, Pisters PW, Chang GJ. Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol. 2011 Oct; 18(10):2800-7. PMID: 21424881.
      View in: PubMed
    151. Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM, Das P. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer. 2011 Aug 15; 117(16):3713-22. PMID: 21328329.
      View in: PubMed
    152. Kwon DS, Chang GJ. The role of minimally invasive surgery and outcomes in colorectal cancer. Perm J. 2011; 15(3):61-6. PMID: 22058671.
      View in: PubMed
    153. You YN, Habiba H, Chang GJ, Rodriguez-bigas MA, Skibber JM. Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2011 Apr; 18(4):989-96. PMID: 21132391.
      View in: PubMed
    154. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am. 2010 Oct; 19(4):847-59. PMID: 20883958.
      View in: PubMed
    155. Luo Y, Shelly L, Sand T, Chang G, Jiang XC. Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein. J Pharmacol Exp Ther. 2010 Dec; 335(3):653-8. PMID: 20805304.
      View in: PubMed
    156. Lee JH, Ross WA, Davila R, Chang G, Lin E, Dekovich A, Davila M. Self-expandable metal stents (SEMS) can serve as a bridge to surgery or as a definitive therapy in patients with an advanced stage of cancer: clinical experience of a tertiary cancer center. Dig Dis Sci. 2010 Dec; 55(12):3530-6. PMID: 20721627.
      View in: PubMed
    157. Overman MJ, Hu CY, Wolff RA, Chang GJ. Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer. 2010 Dec 01; 116(23):5374-82. PMID: 20715162.
      View in: PubMed
    158. Feng B, LaPerle JL, Chang G, Varma MV. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state. Expert Opin Drug Metab Toxicol. 2010 Aug; 6(8):939-52. PMID: 20433402.
      View in: PubMed
    159. Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010 Nov; 17(11):2863-9. PMID: 20552409.
      View in: PubMed
    160. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010 Jun; 210(6):934-41. PMID: 20510802.
      View in: PubMed
    161. Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN. Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer. 2010 May 01; 116(9):2234-41. PMID: 20187100.
      View in: PubMed
    162. Gao H, Steyn SJ, Chang G, Lin J. Assessment of in silico models for fraction of unbound drug in human liver microsomes. Expert Opin Drug Metab Toxicol. 2010 May; 6(5):533-42. PMID: 20233033.
      View in: PubMed
    163. Bowles TL, Xing Y, Hu CY, Mungovan KS, Askew RL, Chang GJ, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN. Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Ann Surg Oncol. 2010 Aug; 17(8):2015-23. PMID: 20369298.
      View in: PubMed
    164. Rao G, Chang GJ, Suk I, Gokaslan Z, Rhines LD. Midsacral amputation for en bloc resection of chordoma. Oper Neurosurg (Hagerstown). 2010 03; 66(Issue suppl_1):ons-41-ons-44. PMID: 20124926.
      View in: PubMed
    165. Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010 Mar 17; 102(6):401-9. PMID: 20185801.
      View in: PubMed
    166. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD. Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem. 2010 Feb 11; 53(3):1098-108. PMID: 20070106.
      View in: PubMed
    167. Chang G, Steyn SJ, Umland JP, Scott DO. Strategic use of plasma and microsome binding to exploit in vitro clearance in early drug discovery. ACS Med Chem Lett. 2010 May 13; 1(2):50-3. PMID: 24900175.
      View in: PubMed
    168. Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg. 2010 Feb; 251(2):261-4. PMID: 19864936.
      View in: PubMed
    169. Schmeler KM, Daniels MS, Soliman PT, Broaddus RR, Deavers MT, Vu TM, Chang GJ, Lu KH. Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome. Obstet Gynecol. 2010 Feb; 115(2 Pt 2):432-4. PMID: 20093870.
      View in: PubMed
    170. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer. 2009 Dec 01; 115(23):5432-40. PMID: 19673001.
      View in: PubMed
    171. Luo Y, Shelly L, Sand T, Reidich B, Chang G, Macdougall M, Peakman MC, Jiang XC. Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes. J Pharmacol Exp Ther. 2010 Mar; 332(3):1100-6. PMID: 19933370.
      View in: PubMed
    172. Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol. 2009 Dec 10; 27(35):5938-43. PMID: 19805670.
      View in: PubMed
    173. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):60-5. PMID: 19695792.
      View in: PubMed
    174. Chang GJ, Gonzalez RJ, Skibber JM, Eng C, Das P, Rodriguez-Bigas MA. A twenty-year experience with adenocarcinoma of the anal canal. Dis Colon Rectum. 2009 Aug; 52(8):1375-80. PMID: 19617747.
      View in: PubMed
    175. Badgwell BD, Chang GJ, Rodriguez-Bigas MA, Smith K, Lupo PJ, Frankowski RF, Delclos G, Du XL, Cormier J. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol. 2009 Oct; 16(10):2752-8. PMID: 19649556.
      View in: PubMed
    176. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009 Aug 01; 27(22):3677-83. PMID: 19470929.
      View in: PubMed
    177. Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):824-30. PMID: 19464823.
      View in: PubMed
    178. Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Delclos ME, Krishnan S, Crane CH, Das P. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):818-23. PMID: 19147305.
      View in: PubMed
    179. Anaya DA, Chang GJ, Rodriguez-Bigas MA. Extracolonic manifestations of hereditary colorectal cancer syndromes. Clin Colon Rectal Surg. 2008 Nov; 21(4):263-72. PMID: 20011437.
      View in: PubMed
    180. Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol. 2008 Nov 10; 26(32):5254-60. PMID: 18854565.
      View in: PubMed
    181. Chang GJ, Lambert LA. Hidden opportunities in cytoreductive surgery for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2008 Nov; 15(11):2993-5. PMID: 18787903.
      View in: PubMed
    182. Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1175-80. PMID: 18207667.
      View in: PubMed
    183. Fleshner PR, Chalasani S, Chang GJ, Levien DH, Hyman NH, Buie WD. Practice parameters for anal squamous neoplasms. Dis Colon Rectum. 2008 Jan; 51(1):2-9. PMID: 18030528.
      View in: PubMed
    184. Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Ellis V, Cleary K, Chang GJ. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008 Jan; 15(1):46-51. PMID: 17985187.
      View in: PubMed
    185. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol. 2008 Jan-Feb; 26(1):9-16. PMID: 18190824.
      View in: PubMed
    186. Badgwell B, Feig BW, Ross MI, Mansfield PF, Wen S, Chang GJ. Pneumoperitoneum in the cancer patient. Ann Surg Oncol. 2007 Nov; 14(11):3141-7. PMID: 17680315.
      View in: PubMed
    187. Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007 Aug; 246(2):215-21. PMID: 17667499.
      View in: PubMed
    188. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA, Crane CH. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007 May 01; 109(9):1750-5. PMID: 17387743.
      View in: PubMed
    189. Gannon CJ, Zager JS, Chang GJ, Feig BW, Wood CG, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007 Jun; 14(6):1870-7. PMID: 17406945.
      View in: PubMed
    190. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Barriers to rehabilitation of colorectal cancer patients. J Surg Oncol. 2007 Apr 01; 95(5):400-8. PMID: 17345598.
      View in: PubMed
    191. Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):794-800. PMID: 17379452.
      View in: PubMed
    192. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007 Mar 21; 99(6):433-41. PMID: 17374833.
      View in: PubMed
    193. Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Janjan NA, Krishnan S, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. Gastrointest Cancer Res. 2007 Mar; 1(2):44-8. PMID: 19262718.
      View in: PubMed
    194. Mullen JT, Rodriguez-Bigas MA, Chang GJ, Barcenas CH, Crane CH, Skibber JM, Feig BW. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol. 2007 Feb; 14(2):478-83. PMID: 17103253.
      View in: PubMed
    195. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71. PMID: 17011451.
      View in: PubMed
    196. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1378-83. PMID: 17056196.
      View in: PubMed
    197. Chang GJ. Laparoscopic treatment of colorectal neoplasia. Curr Treat Options Gastroenterol. 2006 Jun; 9(3):256-64. PMID: 16901389.
      View in: PubMed
    198. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006 Jun; 29(3):219-24. PMID: 16755173.
      View in: PubMed
    199. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Surgical implications of colorectal cancer genetics. Surg Oncol Clin N Am. 2006 Jan; 15(1):51-66, vi. PMID: 16389150.
      View in: PubMed
    200. Chang GJ, Nelson H. Laparoscopic colectomy. Curr Gastroenterol Rep. 2005 Oct; 7(5):396-403. PMID: 16168239.
      View in: PubMed
    201. Chang GJ, Welton ML. Human papillomavirus, condylomata acuminata, and anal neoplasia. Clin Colon Rectal Surg. 2004 Nov; 17(4):221-30. PMID: 20011263.
      View in: PubMed
    202. Chang GJ, Mahanty HD, Ascher NL, Roberts JP. Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant. 2003 Oct; 3(10):1259-63. PMID: 14510699.
      View in: PubMed
    203. Chandler CE, Wilder DE, Pettini JL, Savoy YE, Petras SF, Chang G, Vincent J, Harwood HJ. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J Lipid Res. 2003 Oct; 44(10):1887-901. PMID: 12837854.
      View in: PubMed
    204. Chang GJ, Liu T, Feng S, Bedolli M, O'rourke RW, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery. 2002 Aug; 132(2):149-56. PMID: 12219005.
      View in: PubMed
    205. Chang G, Ruggeri RB, Harwood HJ. Microsomal triglyceride transfer protein (MTP) inhibitors: discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms. Curr Opin Drug Discov Devel. 2002 Jul; 5(4):562-70. PMID: 12197314.
      View in: PubMed
    206. Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum. 2002 Apr; 45(4):453-8. PMID: 12006924.
      View in: PubMed
    207. Jung SI, Chang GJ, Corbascio M, Potts M, Bedolli M, Ascher NI, Freise CF. Expression of intercellular adhesion molecule-1 in the cortex of preserved rat kidneys. J Surg Res. 2001 Sep; 100(1):69-75. PMID: 11516207.
      View in: PubMed
    208. Mahanty HD, Cherikh WS, Chang GJ, Baxter-Lowe LA, Roberts JP. Influence of pretransplant pregnancy on survival of renal allografts from living donors. Transplantation. 2001 Jul 27; 72(2):228-32. PMID: 11477343.
      View in: PubMed
    209. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant. 2000 Dec; 14(6):550-4. PMID: 11127307.
      View in: PubMed
    210. Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl. 2000 Nov; 6(6):734-40. PMID: 11084060.
      View in: PubMed
    211. Berber E, Engle KL, String A, Garland AM, Chang G, Macho J, Pearl JM, Siperstein AE. Selective use of tube cholecystostomy with interval laparoscopic cholecystectomy in acute cholecystitis. Arch Surg. 2000 Mar; 135(3):341-6. PMID: 10722039.
      View in: PubMed
    212. Chang GJ, Woo P, Honda HM, Ignarro LJ, Young L, Berliner JA, Demer LL. Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide. Dependence on pH and oxygen. Arterioscler Thromb. 1994 Nov; 14(11):1808-14. PMID: 7947607.
      View in: PubMed
    213. Keeney S, Chang GJ, Linn S. Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J Biol Chem. 1993 Oct 05; 268(28):21293-300. PMID: 8407967.
      View in: PubMed
    214. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. American Journal of Clinical Oncology: Cancer Clinical Trials.
    215. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointestinal Endoscopy.
    216. 'Watch-and-wait' for rectal cancer. ONCOLOGY (United States). 28.
    217. Ultra-low anterior resection following neoadjuvant chemoradiation for rectal cancer. Seminars in Colon and Rectal Surgery. 24:159-163.
    218. Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer. Annals of Surgical Oncology. 1-8.
    219. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. American Journal of Clinical Oncology: Cancer Clinical Trials.
    220. Anal neoplasia. Seminars in Colon and Rectal Surgery. 14:111-118.
    221. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. American Journal of Clinical Oncology: Cancer Clinical Trials.
    222. Functional Deficits and Symptoms of Long-Term Survivors of Colorectal Cancer Treated by Multimodality Therapy Differ by Age at Diagnosis. Journal of Gastrointestinal Surgery. 19:180-188.
    223. DNA Mismatch Repair Deficiency in Rectal Cancer. Journal of Clinical Oncology. 34:3039-3046.
    224. Condylomata acuminata. Problems in General Surgery. 18:55-64.
    225. Variation in positron emission tomography use after colon cancer resection. Journal of Oncology Practice. 11:e363-e372.
    226. Long-Term results of weekly/daily cisplatin-Based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Diseases of the Colon and Rectum. 57.
    227. Epidemiology and natural history of anal HPV infection and ASIL and cancer in the general population. Seminars in Colon and Rectal Surgery. 15:210-214.
    228. Evidence for improved survival with increased lymph node evaluation in stage II and III colon cancer. American Journal of Hematology/ Oncology. 6:631-633.
    229. Impact of multimodal therapy in locally recurrent rectal cancer. British Journal of Surgery. 103:753-762.
    230. Abdominoperineal resection for distal rectal cancer - For the future, look to the past. American Journal of Oncology Review. 5:282-284.
    231. National Quality Forum Colon Cancer Quality Metric Performance. Annals of Surgery.
    232. Lymph node sampling for rectal cancer. Current Colorectal Cancer Reports. 4:211-217.
    233. Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer. Annals of Surgical Oncology. 1-9.
    234. Epidermal growth factor receptor expression discrepancies in metastatic colorectal cancer patients treated with cetuximab plus irinotecan-based chemotherapy refractory to irinotecan and oxaliplatin. Diseases of the Colon and Rectum. 52:1152-1153.
    235. Hyperfractionated accelerated reirradiation for rectal cancer. Radiotherapy and Oncology.
    236. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget. 7:76250-76260.
    237. Colon, rectum, and anus. 1011-1110.
    238. Early learners as health coaches for older adults preparing for surgery. Journal of Surgical Research. 209:184-190.
    239. Management of anal cancer. 555-566.
    240. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer.
    241. Development of The American society of colon and rectal surgeons' rectal cancer surgery checklist. Diseases of the Colon and Rectum. 59:601-606.
    242. Transthoracic Port Placement Increases Safety of Total Laparoscopic Posterior Sectionectomy. Annals of Surgical Oncology. 1.
    243. Lymph Node Evaluation and Survival in Stage II and III Colon Cancer. Seminars in Colon and Rectal Surgery. 19:26-29.
    244. In Reply. Journal of Clinical Oncology. 27:1918.
    245. Oncological Outcomes After Robotic Proctectomy for Rectal Cancer. Annals of Surgery.
    246. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection. Lung Cancer. 102:108-117.
    247. Clinicopathologic features associated with human papillomavirus/pl6 in patients with metastatic squamous cell carcinoma of the anal canal. Oncologist. 20:1247-1252.
    248. Response. Journal of the National Cancer Institute. 102:1372-1373.
    249. Management and outcomes of anorectal infection in the cancer patient. Diseases of the Colon and Rectum. 53:1103.
    CHANG's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description